This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
But with hundreds of shows available, which ones stand out in 2025? In this article, we spotlight the most influential pharma podcasts of 2025 and explain why they’re worth tuning into. In 2025, pharma podcasts are no longer niche. Pharma podcasts have become a cornerstone of professional development in the life sciences.
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. June 9, 2025.
As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. Companies are investing heavily in digital tools to streamline communication and build stronger connections. From eco-friendly packaging to socially responsible campaigns, sustainability resonates with today’s consumers.
He further highlighted the importance of thorough documentation, communication with regulators, and the need for a comprehensive understanding of the revised Schedule M guidelines. Looking ahead The next session in the PULSE series, focusing on Materials, Vendor Qualification and Reference Standards, is scheduled for January 5, 2025.
June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.
GlobalData Healthcare June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The oligonucleotide market is well-positioned to drive the next wave of personalised treatment. billion from 2021 to 2025 year-to-date. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54
June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The MoU was signed at the BIO International Convention 2025 in Boston, US. The MoU was signed at the BIO International Convention 2025 in Boston, in the US state of Massachusetts. Credit: Department of Health Abu Dhabi.
Inaugurated by Sri Duddilla Sridhar Babu, Minister for IT, Electronics & Communications, Industry & Commerce, and Legislative Affairs, Government of Telangana, the event, themed ‘Epicentre of Progress,’ provided solutions across the entire value chain of industries such as pharma, biotech, chemicals, and food and beverage. .”
Robert Barrie June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The pact is a significant moment for Novo Nordisk, pouring significant resources into research that is not centred around incretins. Struggles at the drugmaker culminated in long-time CEO Lars Fruergaard Jørgensen stepping down in May 2025.
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will support clinical milestones along with AI-driven development across Juvenescence’s portfolio. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global healthcare company M42, which was announced in April 2025.
GlobalData Healthcare June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook European KOLs with cardiomyopathy patients told GlobalData that they are waiting for vutrisiran’s launch for ATTR-wt. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook US health secretary Robert F Kennedy Jr. We may still continue to send you service-related and other non-promotional communications. wants to ensure the ensuing the US does not lag behind other countries in drug development.
Abigail Beaney June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook With potential tariffs and other changes in the US market, it is important for European companies to show they have a scalable model if they want to break into the market. Give your business an edge with our leading industry insights.
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The authorisation in the EU signifies a step forward in eye care for paediatric patients. Credit: chaponta/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is preparing to launch the healthy volunteer segment of a Phase I trial of the therapy in the second half of 2025. The company is preparing to launch the healthy volunteer segment of a Phase I trial of the therapy in the second half of 2025.
June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight. Credit: MargJohnsonVA/Shutterstock. “We Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is studying the therapy in the global Phase IIb PRIZM trial. Credit: Volha_R/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Login Registration is disabled.
Manasi Vaidya June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook A panel at the 2025 BIO International Convention discuss the state of the European biotech funding ecosystem. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will be used to advance Mosanna’s nasal spray for obstructive sleep apnoea. Credit: Pixel-Shot/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Robert Barrie June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Both Kisunla and Leqembi are both approved by the Medicines and Healthcare products Regulatory Agency (MHRA), meaning they will still be available privately. Give your business an edge with our leading industry insights.
June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GATC’s MAT platform identifies potential new drugs and provides comprehensive analytic reports. Credit: Viacheslav Lopatin/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.
Abigail Beaney June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Genomics CEO Professor Sir Peter Donnelly with Justin Ash, CEO of Spire Healthcare. Image credit: Genomics. Oxford-based company Genomics is launching its Health Insights test across the UK, which will be used to predict and prevent diseases.
Abigail Beaney June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The ‘space factory’ will likely be within a satellite, King explained at HLTH Europe. In February 2025, Auxilium’s 3D printer built eight implantable medical devices for peripheral nerve repair on the ISS in two hours.
Abigail Beaney June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Anne Cathrine Fleischer, vice president of Global Obesity Consumer Engagement and New Business Models at Novo Nordisk, announced the platform at HLTH Europe. Give your business an edge with our leading industry insights.
June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The partnership will expand treatment options for mental health in the US. Preparations are underway to introduce Exxua into the US market swiftly, aiming for pharmacy and patient access by late 2025. Credit: Coco Ratta/Shutterstock.
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new facility in Hungary will create 100 local jobs. Credit: SCHOTT Pharma. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Login Registration is disabled.
June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Draig Therapeutics founders: L-R: John Atack, Ruth McKernan and Simon Ward. Credit: Draig Therapeutics/ GlobeNewswire. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook YOLT-101 will be a new treatment possibility for familial hypercholesterolemia. Credit: aipicte/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
Alex Watt June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The delays in market access in individual EU member states have been an obstacle to the industry. Credit: New Africa via Shutterstock. times more products than the overall European average. Give your business an edge with our leading industry insights.
June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Currently in Phase I clinical testing in China, the ADC is expected to enter clinical trials in the US in the third quarter of 2025. In January 2025, AbbVie and Simcere Zaiming entered an option-to-license agreement for the development of SIM0500.
Abigail Beaney June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook NHS England chair Penny Dash speaking with The Sunday Times’ health editor Shaun Lintern. Image credit: Abigail Beaney / GlobalData. Give your business an edge with our leading industry insights. Login Registration is disabled.
June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company leverages machine learning and AI to detect microbial proteins that mimic certain cancer antigens. Recently, Enterome announced its plan to present new data at the International Conference on Malignant Lymphoma (ICML) in Lugano on 21 June 2025.
June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Orion will obtain access to Glykos’ ADC technologies for probable expansion into three new programmes. Credit: Premreuthai/Shutterstock. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.
This article dives deep into how patient marketing has changed, whats driving this transformation, and what strategies are leading the way for 2025 and beyond. The Digital Transformation of Patient Marketing Technology has revolutionized how pharma communicates with patients. How has patient marketing changed in recent years?
Abigail Beaney June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Wes Streeting spoke about the funding, the 10-year plan and other difficulties the NHS has been facing in recent years. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.
AI-based optic systems, for example, can enhance defect screening in manufacturing by scanning for packaging defects. Nature Communications. AI is playing an increasing role in sustainable development 15 and green chemistry by optimizing chemical processes to minimize environmental impact. Internet] FDA. Internet] Deepmatter.
It is critical to understand the supply chain, plan your packaging, storage and distribution lanes, then test the entire process before patient shipments go live. Products are stored and packaged in a dedicated suite by a dedicated team,” explains MacNeir. The requirements When handling personalised medicines, time is of the essence.
June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Navigating customs is increasingly complicated by supply chain turbulence. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. To learn more, download the free whitepaper below. [i]
June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Stargardt disease is a genetic retinal condition, resulting in progressive loss of vision and blindness. We may still continue to send you service-related and other non-promotional communications. Sign up for our daily news round-up!
As the new law unfolds—and as state laws regarding ingredients and packaging, as well as laws regarding environmental claims continue to affect the cosmetics and personal care industries—the topics covered at the conference have never been more relevant.
It is vital that communication, both for beneficiaries and for health care providers and pharmacists, adhere to these principles. Created by and for patient organizations more than 100 years ago, the NHC brings diverse organizations together to forge consensus and drive patient-centered health policy.
It is vital that communication, both for beneficiaries and for health care providers and pharmacists, adhere to these principles. Created by and for patient organizations more than 100 years ago, the NHC brings diverse organizations together to forge consensus and drive patient-centered health policy.
GlobalData Healthcare June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook According to a Novo Nordisk’s speaker at the conference, the company aims to utilise human data input into its target discovery engine. Give your business an edge with our leading industry insights. Login Registration is disabled.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content